Rebiotix
Showing 1 - 8 of 8
Urinary Tract Infections Trial in Saint Louis (Fecal microbiota transplant)
Completed
- Urinary Tract Infections
- Fecal microbiota transplant
-
Saint Louis, MissouriWashington University
Mar 9, 2022
Hepatic Encephalopathy, Cirrhosis, Liver Trial in Jefferson (RBX7455, Placebo)
Recruiting
- Hepatic Encephalopathy
- Cirrhosis, Liver
- RBX7455
- Placebo
-
Jefferson, LouisianaOchsner Medical Center
Sep 21, 2021
Clostridium Difficile Infection Trial in Rochester (RBX7455)
Completed
- Clostridium Difficile Infection
- RBX7455
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 7, 2020
Clostridium Difficile Infection, Infection, Communicable Diseases Trial in Canada, United States (RBX2660)
Active, not recruiting
- Clostridium Difficile Infection
- +2 more
-
Phoenix, Arizona
- +50 more
Jan 11, 2023
Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Standard of Care Antibiotics)
Completed
- Clostridium Difficile Infection
- RBX2660
- Standard of Care Antibiotics
-
Phoenix, Arizona
- +29 more
Mar 25, 2021
Enterocolitis Clostridium Difficile Recurrent Trial in Canada, United States (RBX2660 (microbiota suspension), Placebo)
Completed
- Enterocolitis Clostridium Difficile Recurrent
- RBX2660 (microbiota suspension)
- Placebo
-
Phoenix, Arizona
- +20 more
Dec 23, 2020
Inflammatory Bowel Disease, Ulcerative Colitis Trial in Hamilton, London, Montreal (Fecal Microbiota Enema, Normal Saline Enema)
Completed
- Inflammatory Bowel Disease
- Ulcerative Colitis
- Fecal Microbiota Enema
- Normal Saline Enema
-
Hamilton, Ontario, Canada
- +2 more
Jan 28, 2019